272 Capital’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,351,397
| Closed | -$2.85M | – | 44 |
|
|
2024
Q4 | $2.85M | Sell |
1,351,397
-184,423
| -12% | -$389K | 2.7% | 14 |
|
|
2024
Q3 | $4.13M | Hold |
1,535,820
| – | – | 2.36% | 15 |
|
|
2024
Q2 | $4.38M | Sell |
1,535,820
-1,299,121
| -46% | -$3.7M | 2.19% | 15 |
|
|
2024
Q1 | $12M | Sell |
2,834,941
-104,337
| -4% | -$442K | 4.8% | 4 |
|
|
2023
Q4 | $15.7M | Sell |
2,939,278
-323,717
| -10% | -$1.73M | 5.31% | 4 |
|
|
2023
Q3 | $14M | Buy |
3,262,995
+200,032
| +7% | +$860K | 5.58% | 3 |
|
|
2023
Q2 | $16.8M | Sell |
3,062,963
-345,833
| -10% | -$1.9M | 6.18% | 4 |
|
|
2023
Q1 | $14.3M | Buy |
3,408,796
+221,500
| +7% | +$930K | 5.93% | 2 |
|
|
2022
Q4 | $8.83M | Buy |
3,187,296
+1,472,061
| +86% | +$4.08M | 3.95% | 7 |
|
|
2022
Q3 | $4.39M | Buy |
1,715,235
+170,588
| +11% | +$437K | 2.36% | 11 |
|
|
2022
Q2 | $5.56M | Buy |
1,544,647
+646,211
| +72% | +$2.33M | 2.66% | 9 |
|
|
2022
Q1 | $5.58M | Buy |
898,436
+292,042
| +48% | +$1.81M | 2.67% | 9 |
|
|
2021
Q4 | $4.28M | Buy |
+606,394
| New | +$4.28M | 2.06% | 11 |
|